EUVIMEDEUVIMED entdecken
Crossref

Serum Sirtuin 1 as a potential indicator of disease activity and severity in systemic lupus erythematosus patients

Wafaa Soliman, Ayah T Abdel-Zaher, Amira A Moharram, Nada Saeed, Aya Safar

The Egyptian journal of Immunology · 01.07.2026 · 33 (3) · 36-42

DOI: 10.55133/eji.330305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian journal of Immunology, online erschienen am 01.07.2026. Verfasst von Wafaa Soliman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: Sirtuin 1, Lupus Erythematosus, Systemic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aetiology and pathophysiology of systemic lupus erythematosus (SLE), are yet unclear. Autoantibodies that target various organs and tissues are produced as a result of SLE patients' poor immunological tolerance. Sirtuin-1 (SIRT1) is a histone deacetylase that has a major role in immune responses, apoptosis, and cell differentiation, through alteration of various signalling cascades, including nuclear factor κ-light chain enhancer and activator protein 1 of activated B cells cascades. According to recent data, SIRT1 is an immune system regulator factor, and its impaired action probably play a role in SLE pathogenesis. This study intended to determine whether SIRT1 can be an indicator for SLE severity and activity. This study comprised 30 SLE patients, with a mean age of 28.23 ± 5.21 years and 3.21 ± 1.2 years as duration of the disease. The normal control group consisted of 30 matched adults, aged 27.3±6.22 years (p=0.266). There was a significantly increase in the mean±SD of SIRT1 in SLE patients (28.72±5.83), compared to the control group (22.1±5.59) (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 1Lupus Erythematosus, SystemicHumansFemaleAdultMaleSeverity of Illness IndexBiomarkersYoung Adult

Substanzen

Sirtuin 1SIRT1 protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Department of Internal Medicine, Rheumatology Division, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Department of Medical Microbiology and Immunology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Zitieren

APA

Soliman, W., Abdel-Zaher, A. T., Moharram, A. A., Saeed, N., & Safar, A. (2026). Serum Sirtuin 1 as a potential indicator of disease activity and severity in systemic lupus erythematosus patients. The Egyptian journal of Immunology, 33(3), 36-42. https://doi.org/10.55133/eji.330305

Vancouver

Soliman W, Abdel-Zaher AT, Moharram AA, Saeed N, Safar A. Serum Sirtuin 1 as a potential indicator of disease activity and severity in systemic lupus erythematosus patients. The Egyptian journal of Immunology. 2026;33(3):36-42. doi:10.55133/eji.330305

BibTeX
@article{Soliman2026,
  author = {Soliman, Wafaa and Abdel-Zaher, Ayah T and Moharram, Amira A and Saeed, Nada and Safar, Aya},
  title = {Serum Sirtuin 1 as a potential indicator of disease activity and severity in systemic lupus erythematosus patients},
  journal = {The Egyptian journal of Immunology},
  year = {2026},
  volume = {33},
  number = {3},
  pages = {36--42},
  doi = {10.55133/eji.330305}
}
Kostenlos starten →